| Literature DB >> 11920645 |
Abraham Mittelman1, Alberta Lucchese, Animesh A Sinha, Darja Kanduc.
Abstract
We are studying peptide immunogenicity as a function of the similarity level to the host's proteome. By using as a model the breast/prostate cancer-associated HER-2/neu antigen, we analyzed the monoclonal and polyclonal humoral immune responses against HER-2/neu peptide motifs not shared with the host proteome. We show here that (i) a mouse monoclonal antibody (MAb) raised against the extracellular domain (EC) of human HER-2/neu oncoprotein recognized a linear peptide motif endowed with low similarity level to the mouse proteome; (ii) likewise, human sera from breast/prostate cancer patients preferentially recognized peptide fragments from the EC of the HER-2/neu oncoprotein having sequences that are not present in the human proteome. Together with previous results obtained in other disease models (cervical cancer-associated HPV16 E7 oncoprotein and Pemphigus vulgaris auto-antigen desmoglein-3), the present data suggest that a low level of sequence similarity to the host's proteome might be an important factor in shaping the pool of B cell epitopes. Copyright 2002 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11920645 DOI: 10.1002/ijc.10259
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396